Teva Pharmaceutical Indus (TEVA)
32.64
+0.21 +0.65%
NYSE
Jul 21, 20:00
Delayed 2m
USD
View All Key Stats
TEVA Key Stats
| Income Statement | |
| Revenue (TTM) | 22.72B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 0.01 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 338.00M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 50.07% |
| Profit Margin (Quarterly) | 11.46% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 4.17% |
| Price and Valuation | |
| Market Cap | 33.16B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 1.414 |
| PE Ratio (TTM) | 3264.00 |
| Price to Book Value | 1.091 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 1.018 |
| Free Cash Flow (Quarterly) | 268.00M |
| Return on Equity (TTM) | 1.17% |
View All TEVA News
TEVA News
-
WireHeadlineTime (ET)
-
SA Breaking News07/23 09:53
-
Yahoo07/23 06:38
-
Globe Newswire07/21 18:45
-
Yahoo07/21 13:15
-
MT Newswires07/21 05:50
-
Yahoo07/21 03:28
-
Yahoo07/20 16:38
-
SA Breaking News07/20 07:33
-
MT Newswires07/20 07:31
-
Business Wire07/20 05:00
View All Events
TEVA Events
| Date | Type | Description |
|---|---|---|
| 08/03/2017 07:30 EDT | Misc | Teva Pharmaceutical Industries Ltd Second Quarter Earnings Conference Call in 2017 |
| 08/03/2017 | Earnings | Teva Pharmaceutical Industries Ltd Second Quarter Earnings in 2017 Release |
| 06/01/2017 | Dividends | Amount: 0.34, Declared Date: May 12 2017, Pay Date: Jun 22 2017 |
| 05/11/2017 08:00 EDT | Misc | Teva Pharmaceutical Industries Ltd First Quarter Earnings Conference Call in 2017 |
| 05/11/2017 | Earnings | Teva Pharmaceutical Industries Ltd First Quarter Earnings in 2017 Release |
| 02/28/2017 | Dividends | Amount: 0.34, Declared Date: Feb 13 2017, Pay Date: Mar 20 2017 |
| 02/15/2017 | Misc | Teva Pharmaceutical Industries Ltd Annual Report in 2016 |
| 02/13/2017 08:00 EST | Misc | Teva Pharmaceutical Industries Ltd Fourth Quarter Earnings Conference Call in 2016 |
| 02/13/2017 | Earnings | Teva Pharmaceutical Industries Ltd Fourth Quarter Earnings in 2016 Release |
| 01/06/2017 | Misc | Teva to Host 2017 Business Outlook Conference Call and Webcast on January 6, 2017 |
TEVA Fundamentals
Income Statement View Statement
TEVA Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
TEVA One Page Reports
- One Page Report Download
TEVA Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 32.64 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.tevapharm.com
- Investor Relations URL: http://ir.tevapharm.com/phoenix.zhtml?c=73925&p=irol-irhome
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Next Earnings Release: Aug. 03, 2017
- Last Earnings Release: May. 11, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Jun. 01, 2017
- Description: Teva Pharmaceutical Industries Ltd is a pharmaceutical company which develops, produces and markets generic and specialty medicines which include chemical and therapeutic medicines in a variety of dosage forms and central nervous system medicines.
TEVA Comparables
EditTEVA Excel Add-In Codes
- Name: =YCI("TEVA","name")
- Description: =YCI("TEVA","description")
- Sector: =YCI("TEVA","sector")
- Industry: =YCI("TEVA","industry")
- Est. Current Fiscal Year End: =YCI("TEVA","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other TEVA Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- TEVA Tweets Stocktwits
Advertisement
